JP2006511588A5 - - Google Patents

Download PDF

Info

Publication number
JP2006511588A5
JP2006511588A5 JP2004564285A JP2004564285A JP2006511588A5 JP 2006511588 A5 JP2006511588 A5 JP 2006511588A5 JP 2004564285 A JP2004564285 A JP 2004564285A JP 2004564285 A JP2004564285 A JP 2004564285A JP 2006511588 A5 JP2006511588 A5 JP 2006511588A5
Authority
JP
Japan
Prior art keywords
modafinil
isomer
polymorph
disorders
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004564285A
Other languages
English (en)
Japanese (ja)
Other versions
JP4719471B2 (ja
JP2006511588A (ja
Filing date
Publication date
Priority claimed from FR0216412A external-priority patent/FR2849029B1/fr
Application filed filed Critical
Publication of JP2006511588A publication Critical patent/JP2006511588A/ja
Publication of JP2006511588A5 publication Critical patent/JP2006511588A5/ja
Application granted granted Critical
Publication of JP4719471B2 publication Critical patent/JP4719471B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004564285A 2002-12-20 2003-12-18 モダフィニルの光学異性体の調製方法及び結晶形 Expired - Fee Related JP4719471B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0216412 2002-12-20
FR0216412A FR2849029B1 (fr) 2002-12-20 2002-12-20 Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
PCT/FR2003/003799 WO2004060858A1 (fr) 2002-12-20 2003-12-18 Procede de preparation et formes cristallines des enantiomeres optiques du modafinil

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011032155A Division JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Publications (3)

Publication Number Publication Date
JP2006511588A JP2006511588A (ja) 2006-04-06
JP2006511588A5 true JP2006511588A5 (cg-RX-API-DMAC7.html) 2008-01-24
JP4719471B2 JP4719471B2 (ja) 2011-07-06

Family

ID=32406320

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004564285A Expired - Fee Related JP4719471B2 (ja) 2002-12-20 2003-12-18 モダフィニルの光学異性体の調製方法及び結晶形
JP2011032155A Expired - Lifetime JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011032155A Expired - Lifetime JP5497680B2 (ja) 2002-12-20 2011-02-17 モダフィニルの異性体の調製方法及び結晶形

Country Status (30)

Country Link
US (10) US7132570B2 (cg-RX-API-DMAC7.html)
EP (6) EP2676952A3 (cg-RX-API-DMAC7.html)
JP (2) JP4719471B2 (cg-RX-API-DMAC7.html)
KR (1) KR101050565B1 (cg-RX-API-DMAC7.html)
CN (5) CN100540533C (cg-RX-API-DMAC7.html)
AR (1) AR042546A1 (cg-RX-API-DMAC7.html)
AU (2) AU2003299349C1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0316916B1 (cg-RX-API-DMAC7.html)
CA (2) CA2510096C (cg-RX-API-DMAC7.html)
CL (2) CL2007002450A1 (cg-RX-API-DMAC7.html)
CY (1) CY1114291T1 (cg-RX-API-DMAC7.html)
DK (1) DK2343275T3 (cg-RX-API-DMAC7.html)
EA (1) EA009592B1 (cg-RX-API-DMAC7.html)
EG (1) EG24849A (cg-RX-API-DMAC7.html)
ES (3) ES2575018T3 (cg-RX-API-DMAC7.html)
FR (1) FR2849029B1 (cg-RX-API-DMAC7.html)
HK (1) HK1225371A1 (cg-RX-API-DMAC7.html)
IL (1) IL169205A (cg-RX-API-DMAC7.html)
IS (1) IS7947A (cg-RX-API-DMAC7.html)
MX (1) MXPA05006525A (cg-RX-API-DMAC7.html)
MY (1) MY142926A (cg-RX-API-DMAC7.html)
NO (1) NO335724B1 (cg-RX-API-DMAC7.html)
NZ (2) NZ540733A (cg-RX-API-DMAC7.html)
PL (1) PL377196A1 (cg-RX-API-DMAC7.html)
PT (1) PT2343275E (cg-RX-API-DMAC7.html)
SI (1) SI2343275T1 (cg-RX-API-DMAC7.html)
TW (1) TWI344952B (cg-RX-API-DMAC7.html)
UA (1) UA100964C2 (cg-RX-API-DMAC7.html)
WO (1) WO2004060858A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200504805B (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077894A1 (en) * 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US7790905B2 (en) 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
IL163846A0 (en) 2002-03-01 2005-12-18 Univ South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
IL165383A0 (en) 2002-06-21 2006-01-15 Transform Pharmaceuticals Inc Pharmaceutical compositions with improved dissolution
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7521553B2 (en) * 2003-03-17 2009-04-21 Hetero Drugs Limited Crystalline forms of lamotrigine
WO2004082624A2 (en) * 2003-03-17 2004-09-30 Neurohealing Pharmaceuticals, Inc. Modafinil-based neurorehabilitation of impaired neurological function associated with injury
JP4842819B2 (ja) * 2003-09-04 2011-12-21 セフアロン・インコーポレーテツド モダフィニル組成物
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
EP1516869A1 (en) 2003-09-19 2005-03-23 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
EP2292213A1 (en) * 2004-02-06 2011-03-09 Cephalon, Inc. Compositions comprising a polymorphic form of armodafinil
US20090018202A1 (en) 2004-02-06 2009-01-15 Cephalon, Inc. Modafinil compositions
CA2754932C (en) 2004-07-20 2014-04-01 Warner-Lambert Company Llc Novel forms of [r-(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1)
US20060086667A1 (en) * 2004-09-13 2006-04-27 Cephalon, Inc., U.S. Corporation Methods for the separation of enantiomeric sulfinylacetamides
EP1702915A1 (en) 2005-03-14 2006-09-20 Cephalon France Process for enantioselective synthesis of single enantiomers of thio-substituted arylmethanesulfinyl derivatives by asymmetric oxidation
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
EP1986994A2 (en) * 2006-02-21 2008-11-05 Teva Pharmaceutical Industries Ltd Novel crystalline forms of armodafinil and preparation thereof
EP1954652A2 (en) 2006-03-01 2008-08-13 Teva Pharmaceutical Industries Ltd An improved process for the preparation of armodafinil
JP2009543803A (ja) * 2006-07-12 2009-12-10 エラン・ファルマ・インターナショナル・リミテッド モダフィニルのナノ粒子製剤
DK2056811T3 (en) * 2006-08-14 2018-05-22 Neurohealing Pharmaceuticals Inc Modafinil-based treatment for premature ejaculation
US20080214862A1 (en) * 2006-12-06 2008-09-04 Ben-Zion Dolitzky Processes for preparing armodafinil intermediate
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
CA2688430A1 (en) * 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
WO2009024863A2 (en) * 2007-06-26 2009-02-26 Actavis Group Ptc Ehf Process for the preparation of modafinil enantiomers
US7960586B2 (en) 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090082462A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched armodafinil
US20090105346A1 (en) * 2007-10-02 2009-04-23 Alexandr Jegorov Novel crystalline forms of armodafinil and preparation thereof
WO2009090663A1 (en) * 2008-01-15 2009-07-23 Lupin Limited Novel crystalline polymorph of armodafinil and an improved process for preparation thereof
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US20100036164A1 (en) * 2008-08-06 2010-02-11 Srinivas Areveli Preparation of armodafinil form i
EP2292306B1 (en) 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Method for separation of racemic compound-forming chiral substances by a cyclic crystallization process and a crystallization device
EP2501674A2 (en) * 2009-11-19 2012-09-26 Ranbaxy Laboratories Limited Processes for preparation of polymorphic forms of lacosamide
EP2521546A4 (en) * 2010-01-07 2013-06-26 Vivus Inc TREATMENT OF THE OBSTRUCTIVE SLEEP APNEO SYNDROME COMBINED WITH ANTIBODY ANTIBODY AND AN ADDITIONAL ACTIVE SUBSTANCE
DK2649187T3 (da) 2010-12-08 2018-01-29 Codexis Inc Biokatalysatorer og fremgangsmåder til syntesen af armodafinil
JP6116847B2 (ja) * 2012-10-01 2017-04-19 アムビト バイオサイエンシス コーポレーションAmbit Biosciences Corporation シクロデキストリンとの混合体を含有する錠剤
US10466776B2 (en) * 2014-06-24 2019-11-05 Paypal, Inc. Surfacing related content based on user interaction with currently presented content
US10367985B2 (en) * 2014-07-23 2019-07-30 Orcam Technologies Ltd. Wearable apparatus and method for processing images including product descriptors
RU2674363C1 (ru) * 2014-11-27 2018-12-07 ДжиСи КОРПОРЕЙШН Средство для обработки поверхности восковой модели и способ изготовления зубного протеза
WO2017064723A1 (en) * 2015-10-12 2017-04-20 Natco Pharma Ltd An improved process for the preparation of armodafinil

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1905990A (en) 1931-01-02 1933-04-25 Hoffmann La Roche Disubstituted carbamic acid esters of phenols containing a basic constituent
GB1197809A (en) 1968-02-13 1970-07-08 Inst Noguchi Method for Continuous Optical Resolution of Organic Racemates.
GB1584462A (en) 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2597864B1 (fr) 1986-04-28 1990-11-16 Lafon Labor Nouveaux derives de la n-((trimethoxy-2,4,6-benzoyl)-3 propyl) piperidine, leurs procedes de preparation et leur application en therapeutique
FR2626881B1 (fr) 1988-02-10 1990-07-27 Lafon Labor 1-(4-aminophenyl)-2-hexamethyleneiminopropanone, procede de preparation et utilisation en therapeutique
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2671349B1 (fr) 1991-01-09 1993-04-23 Lafon Labor Nouveaux derives de 1,4-dihydropyridine, leur procede de preparation et composition therapeutique les contenant.
FR2710337B1 (fr) * 1993-09-23 1995-12-08 Gerard Coquerel Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.
US6894171B1 (en) 1998-07-20 2005-05-17 Abbott Laboratories Polymorph of a pharmaceutical
CN1249932A (zh) 1999-09-29 2000-04-12 付俊昌 一种莫达芬尼及其光学对映体l及d异构体的新用途
IL150524A0 (en) 2000-01-07 2003-02-12 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
US20010036640A1 (en) 2000-04-25 2001-11-01 D'amico Kevin L. System and methods for the high throughput screening of polymorphs
US6670358B2 (en) 2000-05-16 2003-12-30 Cephalon, Inc. Substituted thioacetamides
US6492396B2 (en) * 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
DE10025756C2 (de) * 2000-05-25 2003-02-20 Cognis Deutschland Gmbh Lösungsvermittler
WO2005077894A1 (en) 2004-02-06 2005-08-25 Cephalon, Inc. Modafinil compositions
MXPA03000747A (es) * 2000-07-27 2003-06-04 Teva Pharma Modafinilo cristalino y puro y proceso para prepararlo.
US6835307B2 (en) * 2000-08-04 2004-12-28 Battelle Memorial Institute Thermal water treatment
US6919378B2 (en) 2000-10-11 2005-07-19 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
US6489363B2 (en) 2000-10-11 2002-12-03 Cephalon, Inc. Pharmaceutical solutions of modafinil compounds
CN1535139A (zh) 2000-11-03 2004-10-06 ������ҩ��ҵ���޹�˾ 阿伐他丁半钙形式ⅶ
US7297346B2 (en) 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
WO2003014732A1 (en) 2001-08-10 2003-02-20 Symyx Technologies, Inc. Apparatuses and methods for creating and testing pre-formulations and systems for same
EP1466166B2 (en) 2002-01-15 2013-05-01 Avantium International B.V. Method for performing powder diffraction analysis
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US7229644B2 (en) 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
CA2491908C (en) 2002-08-02 2011-09-13 Avantium International B.V. An assembly and method for performing parallel chemical experiments, in particular crystallisation experiments
US6992219B2 (en) 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
CA2508165C (en) 2002-12-06 2014-05-06 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US7566805B2 (en) * 2003-09-04 2009-07-28 Cephalon, Inc. Modafinil compositions
KR101184797B1 (ko) 2003-09-04 2012-09-20 세파론, 인코포레이티드 모다피닐 조성물
US20090018202A1 (en) * 2004-02-06 2009-01-15 Cephalon, Inc. Modafinil compositions
BRPI0516001A (pt) 2004-10-13 2008-08-19 Pharmacia & Upjohn Co Llc formas cristalinas de 3-[5-cloro-4-[(2, 4-difluorobenzil) óxi]-6-oxopirimidin-1(6h)-il]-n-(2-hidroxietil)-4-metilben zamida
EP1909573A4 (en) * 2005-07-21 2010-09-22 Neurohealing Pharmaceuticals I SHORT-TERM EFFECTIVE MODAFINIL COMPOSITIONS WITH A RAPID INITIAL EFFECT, AND METHOD FOR THEIR USE
EP1986994A2 (en) * 2006-02-21 2008-11-05 Teva Pharmaceutical Industries Ltd Novel crystalline forms of armodafinil and preparation thereof
EP1954652A2 (en) 2006-03-01 2008-08-13 Teva Pharmaceutical Industries Ltd An improved process for the preparation of armodafinil
CA2688430A1 (en) 2007-06-04 2008-12-11 Generics [Uk] Limited Novel process
WO2009024863A2 (en) 2007-06-26 2009-02-26 Actavis Group Ptc Ehf Process for the preparation of modafinil enantiomers
US7960586B2 (en) 2007-08-16 2011-06-14 Teva Pharmaceutical Industries Ltd. Purification of armodafinil
US20090105346A1 (en) * 2007-10-02 2009-04-23 Alexandr Jegorov Novel crystalline forms of armodafinil and preparation thereof
EP1911739A3 (en) * 2007-11-05 2008-09-17 Dipharma Francis S.r.l. Crystalline form of (S)-2-phenylethylammonium (R)-diphenyl-methanesulphinyl-acetate
WO2009090663A1 (en) 2008-01-15 2009-07-23 Lupin Limited Novel crystalline polymorph of armodafinil and an improved process for preparation thereof

Similar Documents

Publication Publication Date Title
JP5497680B2 (ja) モダフィニルの異性体の調製方法及び結晶形
JP4271574B2 (ja) ホルモテロールタルトレート法及び多形体
JP4575337B2 (ja) アゴメラチンの新規な結晶形態v、その製造方法、およびそれを含有する薬学的組成物
RU2007103297A (ru) Кристаллические модификации гидрохлорида (-)-(1r, 2r)-3-(3-диметиламино-1-этил-2-метилпропил)фенола
JP2009531358A (ja) 改良された結晶性物質
JP2018024636A (ja) [(2r,3s,4r,5r)−5−(6−(シクロペンチルアミノ)−9h−プリン−9−イル)−3,4−ジヒドロキシテトラヒドロフラン−2−イル]メチルナイトレートの無水多形体及びその製造方法
JP7012725B2 (ja) アセチルサリチル酸リジン・グリシン粒子の改良された合成
JP6908657B2 (ja) 4−[2−ジメチルアミノ−1−(1−ヒドロキシシクロヘキシル)エチル]フェニル4−メチルベンゾエートヒドロクロリドの多形体、それらを作製する方法及びそれらの使用
CN109689620A (zh) 拆分巴氯芬盐的方法
HK1192220A (en) Preparation methods of forms of optical enantiomers of modafinil and pharmaceutical composition thereof
HK1078309B (en) Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
HK1192221A (en) Preparation methods of crystalline forms of optical enantiomers of modafinil and pharmaceutical composition thereof
HK1078309A (en) Method for the production of crystalline forms and crystalline forms of optical enantiomers of modafinil
HK1192222B (en) Preparation method and crystalline form of optical enantiomers of modafinil